ALIGN TECHNOLOGY INC (ALGN) is held by 2 of 149 tracked super-investor funds (144 filed in Q2) in 2026 Q2 13F filings, with 1 fund adding and 1 fund trimming or exiting versus the previous quarter. Latest close $163.96 as of Nov 18, 2026.
Data as of Nov 18, 2026 (prices) · 2026 Q2 13F filings (quarter ended Jun 30, 2026) · Latest Form 4: none in the last 90 days · Congress to Nov 16, 2026.
Ruane Cunniff LP · Disciplined Growth Investors — 2 tracked funds hold ALGN. See all holders.
No insider open-market activity or Congress trades reported for this stock in the recent window. Insider trading · Politician trading.
INTUITIVE SURGICAL INC (ISRG) · ZIMMER BIOMET HOLDINGS, INC. (ZBH) · Edwards Lifesciences Corp (EW) · ESTABLISHMENT LABS HOLDINGS INC. (ESTA) · MSA Safety Inc (MSA) — stocks the same funds also hold. See all related stocks.
| Fund | Portfolio weight | Shares | Change vs prev. quarter |
|---|---|---|---|
| Ruane Cunniff LP | 3.07% | 1,171,455 | TRIMMED (-2.9%) Q3 filed Nov 16 |
| Disciplined Growth Investors | 2.24% | 783,178 | ADDED (+0.9%) Q3 filed Nov 16 |
Source: SEC Form 13F filings, quarter ended Jun 30, 2026. Change labels compare each fund’s 2026 Q2 filing with its previous filing. Fund counts aggregate every share class mapped to this ticker.
Price change since quarter-end: -9.9% from the close on the first trading day after the quarter ended (Jul 1, 2026) to the latest close (Nov 17, 2026). 13F does not report purchase prices — this is the price change since the quarter-end close, not a gain on any fund’s actual purchase.
Filing season: the Q3 2026 13F tracker follows every tracked fund’s filing for the quarter ended Sep 30, 2026, with its biggest buys and sells.
Closing prices (unadjusted for dividends), last 2 years — 501 trading days to Nov 18, 2026. Dashed lines mark 13F filing deadlines. Source: Yahoo Finance daily bars.
| Institutions holding | 674 of 8,857 filers |
| Long-only filers among them | 670 |
| Change vs 2026 Q1 | -10 net · 619 entered · 629 exited |
| Shares reported, all filers | 71,895,178 |
| Reported value, all filers | $12.1B |
Source: SEC Form 13F data sets — every filer's latest report for the quarter ended Jun 30, 2026, not just the tracked funds above; changes compare with the quarter ended Mar 31, 2026. Share counts and values are summed as reported in the filings (a small number of filers report values in thousands of dollars, so value totals are as-filed sums).
| Exchange | Nasdaq |
| Industry | Orthopedic, Prosthetic & Surgical Appliances & Supplies (SIC 3842) |
| Revenue · FY2025 | $4.0B |
| Net income · FY2025 | $410.4M |
| Total assets · FY2025 | $6.2B |
| Shares outstanding | 71,039,852 |
| Market cap (at latest close) | $11.6B |
Source: SEC EDGAR company filings (submissions and company facts), collected Oct 30, 2026. Shares outstanding as reported Jul 31, 2026.
| Shares short · Oct 15, 2026 | 4,147,627 |
| Share of shares outstanding | 5.84% |
| Days to cover | 4.33 |
Shares short at recent settlements — Jul 31, 2026: 4.2M · Aug 14, 2026: 3.4M · Aug 31, 2026: 3.9M · Sep 15, 2026: 3.9M · Sep 30, 2026: 4.2M · Oct 15, 2026: 4.1M.
Source: FINRA Equity Short Interest (biweekly settlement data). Shares outstanding from SEC filings as of Jul 31, 2026.
| Shares failed to deliver · Oct 14, 2026 | 0 |
| Share of shares outstanding | 0.00% |
| Fails as a share of short interest · Oct 15, 2026 | 0.0% |
Fails to deliver at recent settlements — Jul 31, 2026: 0 · Aug 14, 2026: 0 · Aug 31, 2026: 0 · Sep 15, 2026: 0 · Sep 30, 2026: 0 · Oct 14, 2026: 0.
Source: SEC Fails-to-Deliver data (semi-monthly files, published about two weeks after each settlement date). Each figure is the balance of shares not yet delivered on that date; a stock absent from that date’s file counts as zero. See our research on whether fails to deliver predict returns. Shares outstanding from SEC filings as of Jul 31, 2026.
Data unavailable — no Form 4 transactions for this ticker were parsed in the last 90 days.
| Filed | Seller | Role | Shares to sell | Market value | Approx. sale date | Source |
|---|---|---|---|---|---|---|
| Feb 12, 2026 | John Morici | Officer | 7,969 | $1.5M | Feb 12, 2026 | SEC filing |
| Nov 25, 2024 | Wright Emory | Director | 2,500 | $582.4K | Nov 25, 2024 | SEC filing |
| Feb 29, 2024 | JOSEPH S LACOB TTEEFBO JOSEPH S. LACOB REV TRUSTU/A/D 07-19-2007 | Director | 15,000 | $4.5M | Feb 29, 2024 | SEC filing |
| Feb 27, 2024 | JOSEPH S LACOB TTEE FBO JOSEPH S. LACOB REV TRUSTU/A/D 07-19-2007 | Director | 10,000 | $3.1M | Feb 27, 2024 | SEC filing |
| Feb 7, 2024 | Wright Emory | Director | 2,524 | $728.2K | Feb 7, 2024 | SEC filing |
A Form 144 notice is a planned sale, not a completed sale. Most recent first. Source: SEC Form 144 filings, 63,013 notices from Apr 13, 2023 to Oct 9, 2026.
| Filed | Filer | Form | Shares | % owned | Event date | Source |
|---|---|---|---|---|---|---|
| Aug 12, 2026 | Capital World Investors | SC 13G/A | 3,571,496 | 5.0% | Jun 30, 2026 | SEC filing |
| Aug 12, 2026 | G. Zachary Gund, as trustee, sole manager or co-manager | SC 13G/A | 1,875,147 | 2.6% | Jun 30, 2026 | SEC filing |
| Aug 6, 2026 | FMR LLC | SC 13G | 4,060,032.23 | 5.7% | Jun 30, 2026 | SEC filing |
| May 14, 2026 | Capital International Investors | SC 13G/A | 3,906,972 | 5.5% | Mar 31, 2026 | SEC filing |
| May 14, 2026 | Capital World Investors | SC 13G | 4,218,560 | 5.9% | Mar 31, 2026 | SEC filing |
| Apr 29, 2026 | Vanguard Capital Management | SC 13G | 4,975,820 | 6.9% | Mar 31, 2026 | SEC filing |
| Mar 26, 2026 | The Vanguard Group | SC 13G/A | 0 | 0.0% | Mar 13, 2026 | SEC filing |
| Feb 13, 2026 | Capital International Investors | SC 13G | 4,881,512 | 6.8% | Dec 31, 2025 | SEC filing |
| Jan 21, 2026 | BlackRock, Inc. | SC 13G/A | 4,113,442 | 5.7% | Dec 31, 2025 | SEC filing |
| Apr 17, 2025 | BlackRock, Inc. | SC 13G/A | 5,136,805 | 7.0% | Mar 31, 2025 | SEC filing |
One filing is one row; a filing may list several reporters and the first is shown. Figures are as filed, including amendments that report zero shares after a transfer. Source: SEC Schedule 13D/G filings, 57,443 filings parsed to Oct 2, 2026.
Data unavailable — no congressional STOCK Act transactions for this ticker were parsed in the current window (as of Nov 16, 2026).
Industry: Orthopedic, Prosthetic & Surgical Appliances & Supplies (SIC 3842). Standing committees with jurisdiction over this industry: Senate Committee on Health, Education, Labor, and Pensions, House Committee on Energy and Commerce.
None of the members who traded this stock in the current window sit on these committees.
Assignments are the current (119th Congress) rosters. A trade made in an earlier Congress may have been made under a different assignment. Jurisdiction is by industry (SEC SIC code), not by anything the company said or did. Same rule as our committee-jurisdiction study.
Financial Screens
· Piotroski — Financial health improved over the past year
· Earnings Quality (Cash Conversion) — Profits that actually come back as cash
· Shareholder Yield — Cash returned through dividends and buybacks
Key figures
· Piotroski — F-score: 7 · Return on assets: 6.6% · Operating cash flow: $593.2M
· Earnings Quality (Cash Conversion) — Cash conversion (3-yr avg): 1.65 · Operating cash flow: $593.2M · Net income: $410.4M
· Shareholder Yield — Shareholder yield: 4.2% · of which dividends: 0.0% · of which buybacks: 4.2%
Financial screens are computed from SEC company financial statements; red-flag models are screens, not verdicts — see Methodology.
· Insider BEST — appeared in 2 of the last 20 quarterly lists; latest 2025 Q3, ranked #49 of 50.
Also held by the tracked funds that hold ALGN — ranked by lift, the co-holding pattern described in Methodology: INTUITIVE SURGICAL INC (ISRG) · ZIMMER BIOMET HOLDINGS, INC. (ZBH) · Edwards Lifesciences Corp (EW) · ESTABLISHMENT LABS HOLDINGS INC. (ESTA) · MSA Safety Inc (MSA) · STERIS plc (STE) · Enovis CORP (ENOV) · Cadre Holdings, Inc. (CDRE).
8 of the 8 are same-industry (SIC) fillers: fewer than 4 stocks met the lift rule for this stock.
| Filed | Items | Source |
|---|---|---|
| Nov 18, 2026 | 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers · 9.01 Financial Statements and Exhibits | SEC filing |
| Nov 6, 2026 | 1.01 Entry into a Material Definitive Agreement · 2.03 Creation of a Direct Financial Obligation · 9.01 Financial Statements and Exhibits | SEC filing |
| Oct 28, 2026 | 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers · 7.01 Regulation FD Disclosure · 9.01 Financial Statements and Exhibits | SEC filing |
Source: SEC EDGAR Form 8-K filings, latest first. Amendments (Form 8-K/A) are labeled as such. Item labels are the SEC's item titles; a filing can carry several items. Item 5.02 covers both departures and appointments, which this index does not distinguish.
INTUITIVE SURGICAL INC (ISRG) · Track Record: how the signals scored · Practice timing on ALGN
One email a week: the week’s new filings and research. Subscribe free
Open the interactive tool →Live screens, charts and backtests for every tracked stock, fund and signal — free, no sign-up.